OVERLAND PARK, KAN. — In a tactical expansion of its specialized pet care pipeline, global animal health manufacturer Parnell announced the commercial launch of Sevoflurane Inhalation Anesthetic.
The regulatory introduction builds on Parnell’s long-term corporate strategy to establish a single-source, end-to-end anesthetic and sedation ecosystem for companion animal veterinary clinics across North America. Sourced in industry-standard 250 mL glass bottles, the newly available volatile agent is specifically indicated for the rapid induction and maintenance of general anesthesia in canine patients.
Consolidating the Anesthetics Usage
Historically, veterinary clinics have been forced to navigate complex supply chains, multi-vendor pricing matrices, and disparate accountabilities when stocking surgical prep suites and operating tables. The inclusion of Sevoflurane bridges a major gap in Parnell’s anesthesia portfolio.
By adding this fast-acting volatile agent alongside their legacy portfolio, veterinary practices can now source their entire chemical restraint and general anesthesia protocols from a single platform.
“Veterinary professionals place immense trust in the products they use during anesthesia, and that responsibility drives everything we do,” said Pablo Lamberto, DVM, U.S. General Manager at Parnell. “In a category where consistency and reliability matter as much as cost, the addition of Sevoflurane allows us to better support clinics with dependable, high-quality options across the entire anesthesia protocol.”
Pharmacokinetic Advantages: High Turnaround Surgical Situations
In veterinary surgery, sevoflurane is increasingly favored over older halogenated agents like isoflurane or halothane primarily due to its distinct chemical properties.
-
Low Blood/Gas Partition Coefficient: Sevoflurane features exceptionally low blood solubility. This translates to highly predictable, rapid gas uptake and elimination by the canine patient. Mask or chamber inductions run significantly faster, and post-operative recoveries are smooth, quiet, and rapid.
-
Dynamic Precision Control: Because the depth of anesthesia alters almost instantly with adjustments to the vaporizer dials, field anesthetists maintain heightened precision over the animal’s cardiopulmonary stability, making it an excellent choice for geriatric or high-risk cases.
-
Pungency & Safety Profile: Unlike alternative inhalants, sevoflurane is non-pungent and non-irritating to the respiratory tract, drastically reducing airway resistance or coughing during initial induction sequences. It is also nonflammable and nonexplosive, which fits modern clinical workplace safety standards.
